Lacosamide
Lacosamide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Lacosamide; Generic name: LACOSAMIDE; Manufacturer: Amneal Pharmaceuticals of New York LLC.
| Brand name | Lacosamide |
|---|---|
| Generic name | LACOSAMIDE |
| Manufacturer | Amneal Pharmaceuticals of New York LLC |
| Used for | 1 INDICATIONS AND USAGE Lacosamide tablets are indicated for: Treatment of partial-onset seizures in patients 4 years of age and older. (1.1) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older. Additional pediatric use information is approved for UCB, Inc.’s VIMPAT ® (lacosamide) tablets. Ho |
| Dosage | 2 DOSAGE AND ADMINISTRATION Adults (17 years and older): Initial dosage for monotherapy for the treatment of partial-onset seizures is 100 mg twice daily. (2.1) Initial dosage for adjunctive therapy for the treatment of partial-onset seizures or primary generalized tonic-clonic seizures is 50 mg twice daily. (2.1) Maximum recommended dosage for monotherapy and adjunctive therapy is 200 mg twice daily. (2.1) Pediatric Patients 4 years to less than 17 years : The recommended dosage is based on bod |
| Active ingredient(s) | LACOSAMIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e21389b-2f51-4975-aa21-fc5c9dd9f6dc |